ADCT-301

camidanlumab tesirine · ADC Therapeutics S.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ADCT-301, covering 2020-02-26 to 2024-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]